Indications And Dose
Diabetes mellitus ▶BY SUBCUTANEOUS INJECTION ▶Child 2–17 years: According to requirements ▶Adult: According to requirements
Source page 778
Loading InternPractice…
Individual generic drug information
Extracted information for Insulin detemir only.
Diabetes mellitus ▶BY SUBCUTANEOUS INJECTION ▶Child 2–17 years: According to requirements ▶Adult: According to requirements
Source page 778
Extracted information for Insulin detemir only.
→Appendix 1: insulins
Source page 778
▶Uncommon Refraction disorder
Source page 778
Evidence of the safety of long-acting insulin analogues in pregnancy is limited, therefore isophane insulin p. 755 is recommended where longer-acting insulins are needed; insulin detemir may also be considered where longer-acting insulins are needed.
Source page 778
Extracted information for Insulin detemir only.
There can be variation in the licensing of different medicines containing the same drug. Solution for injection ▶Levemir FlexPen (Novo Nordisk Ltd) Insulin detemir 100 unit per 1 ml Levemir FlexPen 100units/ml solution for injection 3ml pre-filled pens | 5 pre-filled disposable injection P £42.00 DT = £42.00 ▶Levemir InnoLet (Novo Nordisk Ltd) Insulin detemir 100 unit per 1 ml Levemir InnoLet 100units/ml solution for injection 3ml pre-filled pens | 5 pre-filled disposable injection P £44.85 DT = £42.00 ▶Levemir Penfill (Novo Nordisk Ltd) Insulin detemir 100 unit per 1 ml Levemir Penfill 100units/ml solution for injection 3ml cartridges | 5 cartridge P £42.00 DT = £42.00 eiiii F 751
Source page 779
Filter the extracted dose blocks for this individual drug.
First line only; read the complete Indications and dose section above.
According to requirements
This is a first-line fragment. Read the full Indications and Dose section above.
Candidate age grouping · source page 778
First line only; read the complete Indications and dose section above.
According to requirements
This is a first-line fragment. Read the full Indications and Dose section above.
Candidate age grouping · source page 778